A new law makes it more difficult for shareholders to challenge corporate decisions through litigation. A second bill headed to the governor’s desk would enhance the fledgling Texas Business Court’s authority, although lawmakers decided for now against expanding the system to rural Texas. (Photo by Ricardo Garza)

What Two Former Texas U.S. Attorney’s Office Heads Want Business Leaders to Know About DOJ Corporate Enforcement in 2025
The C-suite crowd seems to be letting out a collective sigh of relief at the dawn of a perceived era of decreased enforcement, while compliance officers worry aloud about their businesses moving resources to other parts of the company and letting up on their carefully cultivated “cultures of compliance.” We read the room differently, and we thought it important to share seven reasons why there has never been a more important time to keep your compliance frameworks in place and, if possible, provide even more resources to them.
President Names Career Prosecutor as NDTX U.S. Attorney
President Donald Trump has named Nancy E. Larson, a career federal prosecutor, as the Acting United States Attorney for the Northern District of Texas.
Inside a Whistleblower’s Ordeal: Tyler Shultz Details the Battle to Expose Theranos
Tyler Shultz still remembers the exact moment he realized that Theranos, a Silicon Valley health technology startup claiming to have revolutionized blood testing, was a fraud. Shultz shared his story of blowing the whistle on Theranos during a panel discussion hosted by The Texas Lawbook, SMU Dedman School of Law and the SMU Rowling Center for Business Law & Leadership. And he has a powerful call to action for lawyers.
Federal Court Strikes Down FDA’s LDT Final Rule — Implications for Clinical Laboratories
On March 31, a pivotal ruling from the U.S. District Court for the Eastern District of Texas vacated the U.S. Food and Drug Administration’s final rule on laboratory developed tests. The ruling has far-reaching implications for laboratories, healthcare providers and patients.

Bracewell’s Jeff Vaden Weighs in on White-Collar Trends and their Texas Impact
Texas remains a focal point for white-collar litigation amid shifting priorities and an ever-changing enforcement landscape. The Texas Lawbook caught up with white-collar expert Jeff Vaden, a partner in Bracewell’s Houston office, about trends, the Trump Administration’s priorities, what they could mean for Texas and more.
Federal-Style CFIUS Review May Be Coming to Texas
On March 13, the Texas Legislature introduced HB 5007, which, if enacted, would establish the Texas Committee on Foreign Investment, the first U.S. state regime tasked with screening foreign investments on national security grounds. The proposed TCFI is not an entirely new idea; indeed, it closely mimics the responsibilities and purpose of its national regulatory counterpart, the Committee on Foreign Investment in the United States.
Litigation Roundup: SCOTX Decides Barratry Case
In this edition of Litigation Roundup, a Dallas law firm gets another favorable verdict in a mesothelioma trial against Johnson & Johnson, a federal judge in McAllen hands out prison sentences for participants in a $110 million kickback scheme, and the Texas Supreme Court clarifies the limitations of a state law that prohibits the unlawful solicitation of legal clients.
Trump’s First 100 Days Marked by Record Number of Executive Orders
In his second term, President Donald Trump has issued more executive orders in the first 100 days — 35 of them focusing on energy, environmental and infrastructure efforts and law firms — than any other president in history, creating a flurry of governmental actions, broad economic implications and legal challenges, according to a panel of legal experts hosted by The Texas Lawbook.
GT Taps Bill Katz to Co-Chair Antitrust Practice
GT Executive Chairman Richard Rosenbaum in the firm’s announcement highlighted Katz’s experience advising clients in the healthcare and energy industries. Katz had practiced his entire career at Thompson & Knight/Holland & Knight.
- « Go to Previous Page
- Go to page 1
- Go to page 2
- Go to page 3
- Go to page 4
- Interim pages omitted …
- Go to page 45
- Go to Next Page »